Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 1168

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 1168
---
 competitors in the AI industry in order to maintain and grow AI business
and products. Thus, the success of Renovaro Cube’s or BioSymetrics’ AI platform, other products and business depends in large
part on their ability to keep pace with rapid technological changes in the development and implementation of AI products. For example,
the development of groundbreaking technological innovations in AI, or innovations that would render AI obsolete, would harm Renovaro Cube’s
or BioSymetrics’ business and make its platform or other products less durable. Further, the entry of competitors into the AI market
that have more financial and brand power could cause Renovaro Cube’s or BioSymetrics’ share of the market to be significantly
reduced thereby negatively affecting their business, operating results and financial condition.

41

We may not be able to protect
our intellectual property rights throughout the world.

Filing, prosecuting and defending
patents on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property
rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some
foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently,
we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling
or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies
in jurisdictions where we have not obtained patent protection to develop their own products and may also export infringing products to
territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete
with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

Risks Related to Employee
Matters and Managing Growth 

●Our success depends on our ability to attract and retain highly skilled employees in artificial intelligence,
data science, and biomedical research, and competition for such talent is intense.

●We have limited corporate infrastructure and may face challenges in managing growth, which could strain
our resources and delay development.

●Periods of uncertainty or rapid growth may make it difficult to maintain company culture and employee
engagement, which could negatively affect execution of our business objectives.

●The loss of key members of our management or technical teams could disrupt our operations and harm our
business prospects.

●We rely on consultants and contractors for certain